Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes

Table 2 QALYs gained from key musculoskeletal disease interventions, 1994–2013

	Rheumatoid arthritis (M00–06)	Psoriatic arthritis (M07)	Juvenile idiopathic arthritis (M08–09)	Gout (M10–12)	Osteoarthritis (M15–19)	Connective tissue disorders (M30–35)	Ankylosing spondylitis (M45)	Low back pain (M54.5)	Osteoporosis (M80–82)	Total QALYs
1994	698	67	205	1009	1944	6	0	534	0	4464
1995	1181	113	346	1015	2135	7	0	619	287	5703
1996	1786	171	523	1021	2825	8	0	882	287	7504
1997	2513	241	736	1027	3520	10	0	1171	458	9675
1998	3363	322	986	1033	4219	11	0	1468	572	11,973
1999	4964	499	1270	1038	4736	19	33	1624	853	15,036
2000	6449	641	1705	1089	5249	29	33	1847	915	17,957
2001	8459	845	2288	1128	7010	46	51	2070	1749	23,644
2002	9657	956	2641	1183	9500	63	46	2267	2400	28,713
2003	11,409	1137	3146	1245	11,737	85	69	2499	3663	34,990
2004	14,474	1457	4090	1309	14,454	109	197	2795	5022	43,907
2005	13,976	1454	4053	1157	11,504	106	212	2765	5974	41,201
2006	17,450	1361	3769	1135	11,652	129	154	2747	6833	45,229
2007	19,551	1858	5321	1260	12,929	156	367	2786	7921	52,149
2008	23,730	2381	6309	1493	13,386	181	392	4288	8955	61,116
2009	28,588	2662	7756	1471	13,383	195	482	5741	10,252	70,529
2010	33,882	3071	8945	1592	14,451	219	577	6999	11,994	81,729
2011	45,401	4007	11,994	1797	14,625	169	708	8546	12,538	99,786
2012	51,586	4453	13,422	1885	14,726	125	809	8385	13,111	108,502
2013	50,407	4813	13,248	2143	15,153	128	853	8212	12,875	107,834
Total	349,523	32,507	92,753	26,032	189,136	1801	4983	68,245	106,660	871,693
Value	£8738 m	£813 m	£2,319 m	£651 m	£4728 m	£45 m	£125 m	£1706 m	£2667 m	£21,791 m

ISSN: 1478-4505